As an oncogene, BCL6 exerts its transcriptional repression activity by recruiting transcriptional corepressors through its BTB domain, thereby suppressing its target genes, promoting cancer cell proliferation and tumor progression [27, 31–33]. This evidence concerns the gene BCL6 and cancer.